Pfizer-BioNTech and Moderna seek emergency EU approval for COVID-19 vaccine, could be weeks away from rollout

FRANKFURT — Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout could begin this year. Read More

from Canoe https://ift.tt/3fWygZN